Balentine LLC’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,884
| Closed | -$1.05M | – | 255 |
|
|
2024
Q1 | $1.05M | Sell |
4,884
-2,086
| -30% | -$449K | 0.03% | 185 |
|
|
2023
Q4 | $1.47M | Buy |
6,970
+1,317
| +23% | +$277K | 0.05% | 129 |
|
|
2023
Q3 | $1.13M | Buy |
5,653
+367
| +7% | +$73.5K | 0.04% | 132 |
|
|
2023
Q2 | $979K | Buy |
5,286
+298
| +6% | +$55.2K | 0.03% | 156 |
|
|
2023
Q1 | $955K | Sell |
4,988
-3,882
| -44% | -$743K | 0.03% | 187 |
|
|
2022
Q4 | $1.49M | Buy |
8,870
+2,748
| +45% | +$462K | 0.05% | 131 |
|
|
2022
Q3 | $1.08M | Buy |
6,122
+3,571
| +140% | +$632K | 0.04% | 143 |
|
|
2022
Q2 | $522K | Sell |
2,551
-3,262
| -56% | -$667K | 0.02% | 303 |
|
|
2022
Q1 | $1.38M | Buy |
5,813
+4,170
| +254% | +$992K | 0.05% | 116 |
|
|
2021
Q4 | $375K | Buy |
+1,643
| New | +$375K | 0.01% | 214 |
|
|
2020
Q3 | – | Sell |
-477
| Closed | -$78K | – | 286 |
|
|
2020
Q2 | $78K | Buy |
477
+130
| +37% | +$21.3K | ﹤0.01% | 178 |
|
|
2020
Q1 | $60K | Buy |
347
+295
| +567% | +$51K | ﹤0.01% | 163 |
|
|
2019
Q4 | $10K | Buy |
52
+7
| +16% | +$1.35K | ﹤0.01% | 346 |
|
|
2019
Q3 | $10K | Hold |
45
| – | – | ﹤0.01% | 341 |
|
|
2019
Q2 | $9K | Buy |
+45
| New | +$9K | ﹤0.01% | 326 |
|
|
2019
Q1 | – | Sell |
-30
| Closed | -$6K | – | 440 |
|
|
2018
Q4 | $6K | Buy |
+30
| New | +$6K | ﹤0.01% | 310 |
|
|
2018
Q1 | – | Sell |
-54
| Closed | -$8K | – | 151 |
|
|
2017
Q4 | $8K | Hold |
54
| – | – | ﹤0.01% | 479 |
|
|
2017
Q3 | $7K | Hold |
54
| – | – | ﹤0.01% | 489 |
|
|
2017
Q2 | $7K | Hold |
54
| – | – | ﹤0.01% | 466 |
|
|
2017
Q1 | $6K | Hold |
54
| – | – | ﹤0.01% | 454 |
|
|
2016
Q4 | $6K | Hold |
54
| – | – | ﹤0.01% | 439 |
|
|
2016
Q3 | $6K | Buy |
54
+6
| +13% | +$667 | ﹤0.01% | 397 |
|
|
2016
Q2 | $5K | Buy |
+48
| New | +$5K | ﹤0.01% | 404 |
|